Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
12/02/2004 | WO2004103508A2 Use of pulverulent mixtures containing hydrogen peroxide and hydrophobed silicon dioxide for the controlled release of hydrogen peroxide or oxygen |
12/02/2004 | WO2004103409A1 Antitumor agent and process for producing the same |
12/02/2004 | WO2004103408A2 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
12/02/2004 | WO2004103383A1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
12/02/2004 | WO2004103382A1 Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex |
12/02/2004 | WO2004103375A1 Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1 |
12/02/2004 | WO2004103344A1 Combination chemotherapy comprising a liposomal platinum complex |
12/02/2004 | WO2004075849A3 Method and composition for treating hypopigmentation of the hair and skin |
12/02/2004 | WO2004060284A3 Method of using colloidal metal-protein composition for treatment of cancer |
12/02/2004 | WO2004054499A3 Platinum aggregates and process for producing the same |
12/02/2004 | WO2003025119A3 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
12/02/2004 | US20040242651 to gastrointestal systems, kidneys |
12/02/2004 | US20040242504 Novel composition and method for the treatment of hypertension |
12/02/2004 | US20040241705 Method of determining a chemotherapeutic regimen based on glutathione-s-transferase pi |
12/02/2004 | US20040241252 With improved dissolution rates and containing a dissolution rate stabilizer, particularly sodium carboxymethylcellulose, and a secondary release agent, particularly glycine; eliminates formulation and dissolution rate dependencies on raw material density and tablet press parameters |
12/02/2004 | US20040241249 Prepared by ketone extraction of krill; evaporating ketone in liquid product; 2nd extraction of the solids in the product with an alcohol or acetate solvent to form a soluble lipid fraction; separating liquids and solids in 2nd product and evaporating solvent from liquid fraction; recovering solids |
12/02/2004 | US20040237716 Titanium-group metal containing high-performance water, and its producing method and apparatus |
12/02/2004 | DE10321725A1 Enzymhaltige Zusammensetzungen, daraus hergestellte diätetische Lebensmittel und Arzneimittel und ihre Verwendung für medizinische Zwecke Enzyme-containing compositions, dietetic foods and medicines prepared therefrom and their use for medical purposes |
12/02/2004 | DE10321029A1 Arzneimittel mit Selenit Drugs with selenite |
12/02/2004 | CA2634766A1 Pharmaceutical composition containing histone deacetylase inhibitor |
12/02/2004 | CA2634765A1 Pharmaceutical composition containing histone deacetylase inhibitor |
12/02/2004 | CA2634709A1 Pharmaceutical composition containing histone deacetylase inhibitor |
12/02/2004 | CA2527191A1 Cancer treatment comprising a histone deacetylase inhibitor and another anticancer agent |
12/02/2004 | CA2526349A1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
12/02/2004 | CA2526289A1 Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex |
12/02/2004 | CA2526278A1 Combination chemotherapy comprising a liposomal platinum complex |
12/01/2004 | EP1481675A1 Body temperature elevating agents |
12/01/2004 | EP1480687A1 Modified phosphocalcic compound, injectable composition containing same |
12/01/2004 | EP1480659A1 Use of zeolithes for reducing the proportion of lactates and ammonium in human and animal organisms |
12/01/2004 | EP1480658A2 Methods of treating vascular disease |
12/01/2004 | EP1176975A4 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
12/01/2004 | EP1117388A4 Antioxidant gel for gingival conditions |
12/01/2004 | EP1061961B1 Apparatuses and processes for whole-body hyperthermia |
12/01/2004 | CN1551768A Substituted benzimidazole dosage forms and method of using same |
12/01/2004 | CN1177595C Use of composition for increasing insulin activity |
11/30/2004 | US6825188 More potent inhibitors of the vitronectin receptor than the fibrinogen |
11/25/2004 | WO2004100981A1 One or several enzyme-containing compounds, dietetic food products and drugs produced from said compounds and the use therefor for medical purposes |
11/25/2004 | WO2004100896A2 Anti-aging nutritional supplement |
11/25/2004 | WO2004100682A1 A novel composition of complex metal salt of garcinia acid, a process for preparing the same and use thereof |
11/25/2004 | WO2004100681A1 Method for producing a chitosan containing salt having a function of lowering blood pressure |
11/25/2004 | US20040235945 Combining EDTA-sodium-metal complex(es) and the sodium selenite solution to from trace element soultuton to provide the solution to the animals |
11/25/2004 | US20040235796 For therapy of proliferative disease |
11/25/2004 | US20040235795 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids |
11/25/2004 | US20040235736 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
11/25/2004 | US20040234625 Pharmaceutical preparation useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same |
11/25/2004 | US20040234624 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
11/25/2004 | US20040234622 Sulfonamide derivatives |
11/25/2004 | US20040234621 Mixture of catalytic metal compound, coenzyme, reducing agents or oxidizer and adjuvant; applying as aerosol, or film to medical equipment, filters, air conditioner |
11/25/2004 | US20040234620 Aluminum-zirconium compound-based treatment for herpes simplex virus lesions |
11/25/2004 | US20040234589 Mixture with carrier; storage stability packaging; freeze drying |
11/25/2004 | US20040234557 Method for producing a bovine teat dip |
11/25/2004 | US20040234555 Using 5-aminolevulinic acid |
11/25/2004 | US20040234513 Composition and method for reducing blood glucose |
11/25/2004 | US20040234474 mixture of silicone fluid , silica and drug; wound dressing; topical applying; drug delivery |
11/25/2004 | US20040234462 Method of treating a patient's teeth using fluoride releasing glass composition |
11/25/2004 | US20040234457 in situ administering into respiratory system a mixture of organic acid and metal compound |
11/25/2004 | US20040234450 Compositions, methods, apparatuses, and systems for singlet oxygen delivery |
11/25/2004 | US20040234443 reacting calcium hydroxide with carbon dioxide; carbonization; controlling particle sizes; using rotational bed under gravity ; fillers |
11/25/2004 | CA2522404A1 One or several enzyme-containing compounds, dietetic food products and drugs produced from said compounds and the use therefor for medical purposes |
11/24/2004 | EP1479711A1 Multidrop tree branching functional polyethylene glycol, the preparation method and the use of it |
11/24/2004 | EP1479390A1 Pharmaceutical preparation containing selenite |
11/24/2004 | EP1479379A1 Dry liposomal PVP-iodine compositions |
11/24/2004 | EP1478650A1 Novel boronate esters |
11/24/2004 | EP1478396A1 Process for the preparation of a nutrient formulation |
11/24/2004 | EP1478389A1 Treatment for diseases of the eye, inner ear and central nervous system |
11/24/2004 | EP1478375A1 Compositions for the treatment of pilosebaceous gland inflammations comprising aluminium fluoride |
11/24/2004 | EP1478374A1 Formulations comprising psychotropic drugs and selenium |
11/24/2004 | EP1478355A2 Antitumor compositions containing taxane derivatives |
11/24/2004 | EP1154763B1 Patch for transdermal therapy |
11/24/2004 | EP1026945A4 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions |
11/24/2004 | CN1548367A Nano level active carbon and its prepn and use |
11/24/2004 | CN1548076A Liquid composition prepn of magnesium salt and blood circulation promoting and blood clots dispersing Chinese medicine |
11/24/2004 | CN1548057A Transfusing agent of active carbon and its prepn and application in preparing cancer-treating medicine |
11/24/2004 | CN1176724C Herb medicine composition to be contained in sanitary materials for infants |
11/24/2004 | CN1176714C Method and composition for treating prostate cancer |
11/24/2004 | CN1176712C Glossy ganoderma and selenium composite medicine material crude slices |
11/24/2004 | CN1176682C Medicine for treating pulmonary tuberculosis and its preparing process |
11/24/2004 | CN1176681C Chinese medicine compound preparation for comprehensively conditioning functions of human body and its preparing process |
11/24/2004 | CN1176680C Pus drawing out paste for expelling wind and removing obstruction in channels and its preparing method |
11/24/2004 | CN1176676C Blood circulation activating and pain stopping ointment for treating bone injury and its prepn process |
11/24/2004 | CN1176673C Compound ant powder prescription |
11/24/2004 | CN1176672C Face-beautifying ointment and its preparing process |
11/24/2004 | CN1176669C Immune regulator of amino acid calcium from turtle shell and its preparation |
11/24/2004 | CN1176665C Medicine for treating maligant leucoma and its compounding process |
11/24/2004 | CN1176664C Medicine for treating bacillary dysentery and enteritis |
11/24/2004 | CN1176663C Iodostarch paste as laser initiator and its prepn |
11/24/2004 | CN1176662C Medicine for treating dermatopathy |
11/23/2004 | US6822034 Anti-microbial silicone rubber composition and method for making same |
11/23/2004 | US6821997 Associated with a decreased presence of cell-specific carbonic anhydrase enzymes; neurodegenerative conditions, dementia, alzheimer's disease; administering compound to increase ca such as forms of zinc |
11/23/2004 | US6821968 Stable taurolidine electrolyte solutions |
11/23/2004 | US6821780 Complete nutrient medium for use as a cosmetic and cosmetic use thereof |
11/23/2004 | CA2334527C Combination of selenium-containing compounds with cytostatics |
11/18/2004 | WO2004098642A1 Migraine relief composition and methods of using and forming same |
11/18/2004 | WO2004098620A1 Activated carbon infusion solution, preparation method therefor and use thereof for the manufacture of drug for treating cancer |
11/18/2004 | WO2004098619A2 Treating cartilage / bone conditions with water-soluble strontium salts |
11/18/2004 | WO2004098618A2 Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
11/18/2004 | WO2004098617A2 Controlled release composition containing a strontium salt |
11/18/2004 | WO2004098616A1 Method, apparatus, and composition for treating acne |
11/18/2004 | WO2004098571A1 Cold remedy composition comprising zinc salts |
11/18/2004 | US20040229796 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |